HUIYU PHARMACEUTICAL: The company participates in the national centralized drug procurement and intends to be selected

Zhitong
2025.10.28 10:32

HUIYU PHARMACEUTICAL announced that its wholly-owned subsidiary Sichuan HUIYU Haiyue Pharmaceutical Technology Co., Ltd. participated in the bidding work for the 11th batch of national centralized drug procurement organized by the National Organization for Drug Procurement Office. According to the "Public Notice of Proposed Selected Results for National Centralized Drug Procurement" released by the procurement office, the company has one product proposed for selection in this centralized procurement. The proposed selected product is Mesobam Injection, mainly used for the treatment of acute skeletal muscle pain or discomfort symptoms, with a packaging specification of 10ml:1g, and the proposed selected price is 11.59 yuan, with a procurement period until December 31, 2028

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.